Digital dashboards for oral anticoagulation management: a literature scoping review

AS Wilson, DM Triller, A Allen, A Burnett… - Journal of Thrombosis …, 2023 - Springer
This scoping review summarizes the extent and characteristics of the published literature
describing digital population management dashboards implemented to improve the quality …

Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review …

SK Veettil, J Harris, MS Syeed, A Thakkinstian… - Thrombosis …, 2022 - Elsevier
Introduction This meta-analysis was conducted to quantitatively pool the incremental net
benefit (INB) of using direct oral anticoagulants (DOACs) for the prevention of venous …

Screening for clinically relevant drug-drug interactions between direct oral anticoagulants and antineoplastic agents: a pharmacovigilance approach

B Truong, L Hornsby, BI Fox, C Chou, J Zheng… - Journal of Thrombosis …, 2023 - Springer
Background Use of direct oral anticoagulants (DOACs) in patients with cancer remains
suboptimal due to the concern regarding potential drug-drug interactions (DDIs) with …

[HTML][HTML] Advancing anticoagulation stewardship: A call to action for stewardship from the US-based anticoagulation forum

A Burnett, KM Rudd, D Triller - Thrombosis Update, 2022 - Elsevier
Abstract Purpose Anticoagulation Stewardship is urgently needed to improve
anticoagulation management and bend the current, negative trajectory on anticoagulation …

Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations

K Kim, JD Duarte, WL Galanter, J Han, JC Lee… - …, 2023 - Taylor & Francis
Background: The authors aimed to assess outcomes with a pharmacogenetic (PGx)-
informed, pharmacist-guided, personalized consult service for warfarin dosing. Methods …

[HTML][HTML] Contemporary trends and barriers to oral anticoagulation therapy in non-valvular atrial fibrillation during DOAC predominant era

O Sehrawat, AH Kashou, HK Van Houten… - IJC Heart & …, 2023 - Elsevier
There is a need to reassess contemporary oral anticoagulation (OAC) trends and barriers
against guideline directed therapy in the United States. Most previous studies were …

[HTML][HTML] Trends in Drug Spending of Oral Anticoagulants for Atrial Fibrillation, 2014–2021

JS Lee, S Han, NL Therrien, C Park, F Luo… - American journal of …, 2024 - Elsevier
Introduction This study documents cost trends in oral anticoagulants (OAC) in patients with
newly diagnosed atrial fibrillation. Methods Using MarketScan databases, the mean annual …

Anticoagulation Patterns Among Community-Dwelling Older Adults With Atrial Fibrillation

M Costello, EE Tung, KM Fischer… - Journal of Primary …, 2024 - journals.sagepub.com
Objectives: To assess clinicians' prescribing practices for anticoagulation in older adults with
atrial fibrillation or atrial flutter (AF/F) and determine factors common among those without …

Digital dashboards for direct oral anticoagulant surveillance, intervention and operational efficiency: uptake, obstacles, and opportunities

DM Triller, AS Wilson, AL Allen, AE Burnett… - Journal of Thrombosis …, 2024 - Springer
Direct oral anticoagulants (DOAC) are the most widely prescribed oral anticoagulants in the
United States. Despite advantages over warfarin, system-level improvements are needed to …

Transitioning to Unfractionated Heparin in Treatment of Non-ST-Segment Elevation Myocardial Infarction Patients on Direct Oral Anti-Xa Inhibitors

M Tashani, RA Stevens… - Cellular and Molecular …, 2023 - cellmolbiol.org
The heparin anti-Xa assay is affected by the use of direct oral anticoagulants (DOACs) and
is utilized in the management of intravenous unfractionated heparin. Patients with non-ST …